2m 2m 2m 2m 2m 2m 2m
Cytokinetics (CYTK)
NASDAQ
$79.91-$0.11 (-0.13%)
Price as of Jun 23, 2026 7:30 PM EDT- $10.7BMarket Cap
- 142.56%1-Year Change
- BiotechnologyIndustry
Cytokinetics (CYTK)
$79.91-$0.11 (-0.13%)
CYTK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $80.01 | ||
Change | +$0.39 (+0.50%) | ||
Open | $78.99 | ||
High | $80.40 | ||
Low | $78.27 | ||
Previous Close | $79.17 | ||
Volume | 2,077,559 | ||
30-Day Average Volume | 2,028,363 | ||
1-Week Change | 10.91% | ||
1-Month Change | 2.90% | ||
1-Year Change | 142.56% | ||
3-Year Change | 112.71% | ||
5-Year Change | 257.43% | ||
Fundamentals | |||
Shares Outstanding | 135.8M | ||
Total Assets | $1.3B | ||
Market Cap | $10.7B | ||
Enterprise Value | $10.9B | ||
Period: QTR TTM FY | |||
Revenue | $4.8M | ||
Net Income | -$206.0M | ||
Free Cash Flow | -$151.4M | ||
EBIT | -$191.5M | ||
EBITDA | -$188.1M | ||
Net Working Capital | $640.3M | ||
EPS | -$1.67 | ||
Enterprise Value/EBITDA | -58 | ||
Enterprise Value/Revenue | 2,278 | ||
P/B | -13 | ||
P/E | -47 | ||
PEG | -0 | ||
Price/Free Cash Flow | -71 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/25/2013 | ||
Earnings & Revenue